We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-4.28%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.1B
AUM Growth
-$154M
(-0.76%)
Cap. Flow
+$988M
Cap. Flow
% of AUM
4.91%
Top 10 Holdings %
Top 10 Hldgs %
28.47%
Holding
777
New
61
Increased
377
Reduced
301
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$252M |
| 2 |
Nutrien
NTR
|
+$196M |
| 3 |
B
Barrick Mining
B
|
+$180M |
| 4 |
Franco-Nevada
FNV
|
+$165M |
| 5 |
GG
Goldcorp Inc
GG
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGU
Agrium
AGU
|
+$169M |
| 2 |
Union Pacific
UNP
|
+$63.1M |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
+$43M |
| 4 |
CPE
Callon Petroleum Company
CPE
|
+$38.5M |
| 5 |
Louisiana-Pacific
LPX
|
+$31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 51.82% |
| 2 | Energy | 17.22% |
| 3 | Healthcare | 6.47% |
| 4 | Technology | 5.7% |
| 5 | Consumer Discretionary | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Guidewire Software
GWRE
$12.4B
| $16.1M | 0.08% |
198,623
-33,960
| -15% | -$2.73M |
|
202
Vale
VALE
$62.9B
| $16M | 0.08% |
1,261,020
+161,671
| +15% | +$2.13M |
|
|
NE
203
DELISTED
Noble Corporation
NE
| $16M | 0.08% |
4,311,582
+658,072
| +18% | +$2.93M |
|
|
GPL
204
DELISTED
Great Panther Mining Limited
GPL
| $15.6M | 0.08% |
1,336,392
+28,088
| +2% | +$349K |
|
205
Sociedad Química y Minera de Chile
SQM
$19.6B
| $15.6M | 0.08% |
317,338
+25,255
| +9% | +$1.37M |
|
206
Qorvo
QRVO
$7.92B
| $14.9M | 0.07% |
212,122
-1,881
| -0.9% | -$142K |
|
207
Ternium
TX
$9.37B
| $14.6M | 0.07% |
450,435
+56,356
| +14% | +$1.91M |
|
208
Perrigo
PRGO
$1.4B
| $14.5M | 0.07% |
173,996
-8,536
| -5% | -$745K |
|
209
Main Street Capital
MAIN
$5B
| $14.5M | 0.07% |
392,447
-18,367
| -4% | -$688K |
|
|
CCT
210
DELISTED
Corporate Capital Trust, Inc.
CCT
| $14.4M | 0.07% |
+849,171
| New | +$13.6M |
|
211
Toro Company
TTC
$9.01B
| $14.3M | 0.07% |
228,945
+14,746
| +7% | +$940K |
|
212
Prospect Capital
PSEC
$1.12B
| $13.4M | 0.07% |
2,052,603
-317,381
| -13% | -$2.12M |
|
213
GSK
GSK
$104B
| $13.1M | 0.07% |
268,806
-42,299
| -14% | -$1.97M |
|
|
ANTX
214
DELISTED
Anthem, Inc.
ANTX
| $13M | 0.06% |
242,444
+5,875
| +2% | +$337K |
|
|
CAVM
215
DELISTED
Cavium, Inc.
CAVM
| $13M | 0.06% |
163,738
+11,427
| +8% | +$997K |
|
216
AstraZeneca
AZN
$263B
| $13M | 0.06% |
185,696
-23,899
| -11% | -$1.66M |
|
|
DCUD
217
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $12.6M | 0.06% |
271,537
+6,581
| +2% | +$324K |
|
218
Sanofi
SNY
$105B
| $12.6M | 0.06% |
313,775
+1,575
| +0.5% | +$65.5K |
|
219
Johnson & Johnson
JNJ
$641B
| $12.4M | 0.06% |
97,022
+1,681
| +2% | +$227K |
|
220
Novartis
NVS
$297B
| $12.4M | 0.06% |
170,742
-9,863
| -5% | -$751K |
|
|
NVO
221
Novo Nordisk
NVO
$220B
| $12.2M | 0.06% |
494,554
-21,970
| -4% | -$577K |
|
222
Qiagen
QGEN
$8.47B
| $12M | 0.06% |
350,190
-90,598
| -21% | -$3.18M |
|
|
VEDL
223
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $11.9M | 0.06% |
678,853
+85,208
| +14% | +$1.72M |
|
224
Jazz Pharmaceuticals
JAZZ
$16B
| $11.7M | 0.06% |
77,553
-9,366
| -11% | -$1.37M |
|
225
Bausch Health
BHC
$1.67B
| $11.5M | 0.06% |
723,123
+33,987
| +5% | +$633K |
|
Similar funds
DAM
VanEck Associates's Q1 2018 Portfolio in Review
As of Q1 2018, VanEck Associates held 777 positions worth $20.1B, down 0.76% from $20.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
VanEck Associates deployed $988M of net new capital in Q1 2018, opening 61 new positions and adding to 377 existing holdings. Its largest new stake was Nutrien: 3,920,000 shares worth $185M.
By sector, the portfolio is most concentrated in Materials at 52% of assets, up from 50% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Louisiana-Pacific, an estimated $31M trimmed.
- VanEck Associates's largest Q1 2018 buy was Nutrien: 3,920,000 shares worth $185M.
- VanEck Associates added most to Newmont in Q1 2018, an estimated $252M increase.
- VanEck Associates's biggest Q1 2018 reduction was Louisiana-Pacific, cutting an estimated $31M.
- VanEck Associates fully exited Agrium in Q1 2018, selling an estimated $169M.
- VanEck Associates's ten largest holdings make up 28% of its $20.1B portfolio in Q1 2018.
- VanEck Associates opened 61 new positions and closed 33 in Q1 2018.
- VanEck Associates's portfolio value fell 0.76% quarter-over-quarter to $20.1B.
Based on VanEck Associates's 13F filing for Q1 2018, filed 11 May 2018.